Zacks Research Issues Positive Estimate for Humana Earnings

Humana Inc. (NYSE:HUM) – Analysts at Zacks Research boosted their Q1 2027 earnings estimates for Humana in a research note issued to investors on Wednesday, August 12th. Zacks Research analyst Team now forecasts that the insurance provider will post earnings of $9.04 per share for the quarter, up from their previous estimate of $8.70. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Humana’s current full-year earnings is $9.09 per share.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm had revenue of $40.89 billion during the quarter, compared to analyst estimates of $40.58 billion. During the same quarter in the previous year, the business earned $6.27 earnings per share. Humana’s quarterly revenue was up 26.2% on a year-over-year basis.

HUM has been the topic of several other research reports. Sanford C. Bernstein restated an “outperform” rating and set a $425.00 price target on shares of Humana in a research note on Wednesday, June 3rd. Wells Fargo & Company raised shares of Humana from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $227.00 to $502.00 in a research note on Monday, July 13th. Leerink Partners upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $513.00 target price on the stock in a report on Thursday, July 30th. Raymond James Financial downgraded shares of Humana from an “outperform” rating to a “market perform” rating in a research report on Thursday, July 30th. Finally, Needham & Company LLC began coverage on shares of Humana in a report on Wednesday, May 20th. They issued a “buy” rating for the company. Fourteen equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $395.22.

Humana Trading Up 4.3%

Shares of NYSE HUM opened at $388.86 on Thursday. Humana has a twelve month low of $163.11 and a twelve month high of $428.88. The firm has a market cap of $46.69 billion, a PE ratio of 36.79, a price-to-earnings-growth ratio of 2.13 and a beta of 0.72. The business has a fifty day simple moving average of $380.56 and a two-hundred day simple moving average of $274.05. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62.

Hedge Funds Weigh In On Humana

Several institutional investors and hedge funds have recently bought and sold shares of the company. Wilkerson Advisory Group LLC lifted its position in Humana by 24.6% during the second quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock valued at $66,000 after buying an additional 33 shares in the last quarter. Bogart Wealth LLC grew its holdings in Humana by 192.0% during the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after acquiring an additional 48 shares in the last quarter. Fiduciary Alliance LLC raised its stake in Humana by 0.9% during the first quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock valued at $976,000 after buying an additional 49 shares in the last quarter. Sanctuary Advisors LLC lifted its stake in Humana by 1.6% during the fourth quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider’s stock worth $868,000 after purchasing an additional 52 shares during the last quarter. Finally, Horizon Investments LLC lifted its position in shares of Humana by 2.5% in the 4th quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider’s stock worth $573,000 after buying an additional 55 shares during the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.